Mobile Menu

Brand Name Pharmaceutical Manufacturing in Oklahoma

Author.Name IBISWorld United States Last Updated: April 2025 NAICS OK32541a

Brand Name Pharmaceutical Manufacturing in Oklahoma industry analysis

The Brand Name Pharmaceutical Manufacturing industry in Oklahoma is expected to grow an annualized x% to $x.x million over the five years to 2025, while the national industry will likely grow at x.x% during the same period. Industry establishments stagnated an annualized x% to xx locations. Industry employment has increased an annualized x% to xxx workers, while industry wages have increased an annualized x.x% to $x.x million.

Over the five years to 2030, the industry is expected to grow an annualized x% to $x.x million, while the national industry is expected to grow x.x%. Industry establishments are forecast to stagnate x% to xx locations. Industry employment is expected to increase an annualized x.x% to xxx workers, while industry wages are forecast to increase x% to $x.x million.

Unbiased research for even more industries at your fingertips

  • 5000+Industries covered
  • 100+Local analysts
  • 250k+Hours of detailed analysis
  • 100k+Subscriber community

Purchase a membership to access this industry and so much more.

About the Brand Name Pharmaceutical Manufacturing in Oklahoma Market Research Report

What’s Included in the Brand Name Pharmaceutical Manufacturing in Oklahoma Market Research Report

Definition of the Brand Name Pharmaceutical Manufacturing in Oklahoma?

Brand name pharmaceutical manufacturers develop, produce and market pharmaceutical drugs under their proprietary brand names. These manufacturers often hold patents or other intellectual property rights to their drugs, granting them sole exclusivity to produce, distribute and sell their drug for the entire life of the patent.

What’s included in the Brand Name Pharmaceutical Manufacturing in Oklahoma?

The Brand Name Pharmaceutical Manufacturing in Oklahoma includes pharmaceutical research and development, manufacturing chemical pharmaceutical preparations and manufacturing biological pharmaceutical products. Related terms covered in the Brand Name Pharmaceutical Manufacturing in Oklahoma industry report includes a drug made from large-molecule living matter, as opposed to small-molecule chemicals, a drug derived from living organisms and marketed after the patent expiration of similar therapies. also known as flow-on biologics or biogenerics, a pharmaceutical or medicine designed to treat certain rare diseases, the period when numerous patents on blockbuster drugs are set to expire, to procure goods or services under contract with an outside supplier, medicines that may be sold directly to a consumer without a prescription from a healthcare professional, a blockbuster drug is a pharmaceutical product that generates significant revenue for its manufacturer, typically through high sales volume. blockbuster drugs are characterized by their ability to generate annual sales exceeding $1.0 billion or even several billion dollars and a strategy used by pharmaceutical companies to extend the patent life of a drug beyond its original expiration date by modifying or improving an aspect of the patented drug.

Industry Performance of the Brand Name Pharmaceutical Manufacturing industry in Oklahoma

Benchmark the Brand Name Pharmaceutical Manufacturing in Oklahoma industry performance with all OK county and national performance.

Brand Name Pharmaceutical Manufacturing in Oklahoma

#46 in Highest Revenue 0% of state's GDP
Revenue (2025)
Annual Growth (2020-25)
Annual Growth (2025-30)

Brand Name Pharmaceutical Manufacturing in the US


Revenue (2025)
Annual Growth (2020-25)
Annual Growth (2025-30)

For the full list of industry drivers, see report purchase options.

Key Drivers of the Brand Name Pharmaceutical Manufacturing industry in Oklahoma

See how key industry drivers, such as population, gross state product, per capita disposable income, research and development expenditure, number of people with private health insurance and investor uncertainty are impacting Brand Name Pharmaceutical Manufacturing in Oklahoma

Oklahoma Economic Indicators

Population
Gross State Product
Per Capita Disposable Income

View more economic information in OK State Economic profile

US Key External Drivers

Research and development expenditure
Number of people with private health insurance
Investor uncertainty

For the full list of industry drivers, see report purchase options.

County Data of the Brand Name Pharmaceutical Manufacturing industry in Oklahoma

Access proprietary data on county in the Brand Name Pharmaceutical Manufacturing in Oklahoma, such as Oklahoma County, Tulsa County and Cleveland County. Data includes figures on revenue, establishments, employees and wages by counties.

Key Statistics of the Brand Name Pharmaceutical Manufacturing industry in Oklahoma

Download 18 years of historical data and 5 years of projected performance.

Need a deeper insight
Get a free tour

Free Tour

Top Questions Answered in this Report

Unlock comprehensive answers and precise data upon purchase. View purchase options.

What is the market size of the Brand Name Pharmaceutical Manufacturing industry in Oklahoma in 2025?

The market size of the Brand Name Pharmaceutical Manufacturing industry in Oklahoma is $74.1m in 2025.

How many businesses are there in the Brand Name Pharmaceutical Manufacturing industry in Oklahoma in 2025?

There are 15 businesses in the Brand Name Pharmaceutical Manufacturing industry in Oklahoma, which has been declining at an average annual rate of 0.0% from 2020 to 2025.

Has the Brand Name Pharmaceutical Manufacturing industry in Oklahoma grown or declined over the past 5 years?

The market size of the Brand Name Pharmaceutical Manufacturing industry in Oklahoma has been growing at an average annual rate of 9.0% from 2020 to 2025.

How many employees in the Brand Name Pharmaceutical Manufacturing industry in Oklahoma in 2025?

There are 493 employees in the Brand Name Pharmaceutical Manufacturing industry in Oklahoma, which has been growing at an average annual rate of 4.0% from 2020 to 2025.